Medline has officially launched the biggest IPO of 2025 — and investors are paying attention.<br /><br />The medical supplies giant raised $6.26 billion in its Nasdaq debut, pricing shares at $29 each in an upsized offering backed by private equity heavyweights Blackstone, Carlyle, and Hellman & Friedman. Founded in 1966, Medline supplies hospitals worldwide and has posted consistent growth across economic cycles, including the pandemic.<br /><br />In this video, we break down why Medline’s IPO matters, the risks from tariffs heading into 2026, and why Wall Street believes this debut could reopen the IPO window for massive names like SpaceX, Anthropic, and potentially OpenAI.<br /><br />This is more than just one stock — it’s a signal for the future of public markets.
